Sarcopenic Obesity and Endocrinal Adaptation with Age
Open accessThe DOI matches its Crossref record; 182 of the 183 references it cites were found in a registry or an index.
Abstract
In normal aging, changes in the body composition occur that result in a shift toward decreased muscle mass and increased fat mass. The loss of muscle mass that occurs with aging is termed sarcopenia and is an important cause of frailty, disability, and loss of independence in older adults. Age-related changes in the body composition as well as the increased prevalence of obesity determine a combination of excess weight and reduced muscle mass or strength, recently defined as sarcopenic obesity. Weight gain increases total/abdominal fat, which, in turn, elicits inflammation and fatty infiltration in muscle. Sarcopenic obesity appears to be linked with the upregulation of TNF- α , interleukin (IL)-6, leptin, and myostatin and the downregulation of adiponectin and IL-15. Multiple combined exercise and mild caloric restriction markedly attenuate the symptoms of sarcopenic obesity. Intriguingly, the inhibition of myostatin induced by gene manipulation or neutralizing antibody ameliorates sarcopenic obesity via increased skeletal muscle mass and improved glucose homeostasis. In this review, we describe the possible influence of endocrinal changes with age on sarcopenic obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, obesity in the elderly can favor joint dysfunction, chronic pain, disabilities relating to activities of daily living, and frailty, damaging functional status more than obesity or sarcopenia alone [31, 67–70].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the age of 70 years, fat-free mass and fat mass tend to decrease in parallel.21”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Aging comes with is a decrease in anabolic hormones such as testosterone and GH.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“The pathophysiology of this condition involves a complex interplay between muscle, adipose tissue, hormonal changes, inflammation, oxidative stress and lifestyle factors, among others.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [48]
In the citing paper
“IR is a feature of aging and obesity in humans and rodents.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [31]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600
RetractedPharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
HASKELL, W. L., LEE, I.-M., PATE, R. R., POWELL, K. E., BLAIR, S. N., FRANKLIN, B. A., MACERA, C. A., HEATH, G. W., THOMPSON, P. D., & BAUMAN, A. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180616b27 · Cited by 4,616
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin stimulates fatty acid oxidation and glucose uptake in skeletalmuscle [126] and adipose tissue [127], effects which are dependent on AMP-activated protein kinase (AMPK) signaling.”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013 · cited 2×
“[105] A.”
BackgroundBody-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Research works printed but not linked: 1
- Sakuma K Yamaguchi A Perloft JW Wong AH Sarcopenia: molecular mechanisms and current therapeutic strategy Cell Aging 2011 New York, NY, USA Nova Science 93 152
Cited by
Items 101–200 of 230
Endocrinological aspects of sarcopenic obesity
Minnetti, M., Poggiogalle, E., Frigerio, F., Piciocchi, C., Pierantozzi, G., Vincenzo, O. D., Pinto, A., Gianfrilli, D., Isidori, A. M., Migliaccio, S., et al. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2626085 · Cited by 14
“Among the various pathophysiological mechanisms implicated in the development of SO, endocrine dysfunction plays a pivotal role (Table 1) [6].”
Yamagishi, S., Okamura, Y., Kang, W., Shindate, M., Kochi, M., Mitsuka, Y., Watabe, M., Yoshida, N., Ikarashi, M., Yamazaki, S., et al. (2023) · Digestive Surgery · doi:10.1159/000531797 · Cited by 14
“Sarcopenic obesity is not only an overlapping condition but is also thought to be associated with more substantial metabolic abnormalities and dysfunction and greater cardiovascular risk, and its effects have been re-ported in cancer patients [16 – 18].”
BackgroundTroponin T3 associates with DNA consensus sequence that overlaps with p53 binding motifs
López, Y. O. N., Messi, M. L., Pratley, R. E., Zhang, T., & Delbono, O. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.03.012 · Cited by 14
Polo-Ferrero, L., Navarro-López, V., Fuentes, M., Lacal, J., Cancelas-Felgueras, M. D., Santos-Blázquez, N., Méndez-Sánchez, R., & Sánchez-González, J. L. (2025) · Nursing Reports · doi:10.3390/nursrep15030089 · Cited by 13
Ichinoseki‐Sekine, N., Kakigi, R., Miura, S., & Naıto, H. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0736-6 · Cited by 13
“Reduced muscle mass in aged individuals leads to sarcopenia [5, 8], which causes disability and loss of independence, and is associated with decreased survival rates following critical illness [9].”
BackgroundSilveira, É. A., de Souza, J. D., Santos, A. S. E. A. D. C., Canheta, A. B. D. S., Pagotto, V., & Noll, M. A. (2020) · Archives of Public Health · doi:10.1186/s13690-020-00454-7 · Cited by 13
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women
Park, J. Y., Chung, Y., Song, J., Kil, K., Lee, H. Y., Chae, J., & Kim, J.-H. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24004 · Cited by 13
Sarcopenic obesity: pathogenesis, epidemiology and management in older adults
Glavas, C., & Scott, D. S. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2543811 · Cited by 12
“Declining levels of anabolic hormones such as testosterone, growth hormone, and insulin-like growth factor (IGF-1) reduce protein synthesis, impair cellular activation and dysregulate the promotion of myogenesis [26–28].”
Body Composition in Chronic Liver Disease
Nishikawa, H., Kim, S. K., & Asai, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020964 · Cited by 12
Haruna, K., Minami, S., Miyoshi, N., Fujino, S., MIZUMOTO, R., Toyoda, Y., Hayashi, R., Kato, S., Takeda, M., Sekido, Y., et al. (2024) · Cancers · doi:10.3390/cancers16193429 · Cited by 12
“Additionally, increased secretion of adiponectin and leptin reduces insulin sensitivity in the muscles, resulting in muscle mass loss [21,22].”
Backgroundde Souza, L. F., Fontanela, L. C., Leopoldino, A. A. O., Mendonça, V. A., Danielewicz, A. L., Lacerda, A. C. R., & de Avelar, N. C. P. (2023) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2022.0141.r1.17082022 · Cited by 11
Morioka, T., Mori, K., Motoyama, K., & Emoto, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55720-3_14 · Cited by 11
Alves Guimarães, M. S., Araújo dos Santos, C., da Silva Castro, J., Juvanhol, L. L., Canaan Rezende, F. A., Martinho, K. O., & Ribeiro, A. Q. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.004 · Cited by 10
Sarcopenic obesity and brain health: A critical appraisal of the current evidence
Booranasuksakul, U., Guan, Z., Macdonald, I. A., Tsintzas, K., Stephan, B. C. M., & Siervo, M. (2025) · Nutrition Bulletin · doi:10.1111/nbu.12725 · Cited by 10
Wang, Z.-Z., Xu, Q., Zhang, Y., Wu, R., Cui, J.-L., Zhou, J., & Hong, J. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00914-3 · Cited by 9
“For example, aging is associated with a gradual decline in muscle mass and function, and an increase in fat mass with redistribution to metabolically deleterious depots [52].”
Díaz-López, K. D. J., & Caire‐Juvera, G. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2020.1833791 · Cited by 9
Nakano, R., Takebe, N., Ono, M., Hangai, M., Nakagawa, R., Yashiro, S., Murai, T., Nagasawa, K., Takahashi, Y., Satoh, J., et al. (2017) · Obesity Science & Practice · doi:10.1002/osp4.97 · Cited by 8
“While the management of multiple geriatric disorders is regarded as a critical issue, the pathogenesis of sarcopenic obesity-related atherosclerosis remains unclear (16).”
Hosoi, N., Shiraishi, T., Okada, T., Osone, K., Yokobori, T., Sakai, M., Ogawa, H., Sohda, M., Shirabe, K., & Saeki, H. (2024) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12845 · Cited by 8
Abad-González, Á. L., Martín, S. V., Argente, M., Civera, M., García-Malpartida, K., Juan, C. S., Artero, A., Palmas-Candia, F. X., Perelló-Camacho, E., Salom, C., et al. (2025) · Nutrients · doi:10.3390/nu17030499 · Cited by 8
“Aging also leads to increased body fat, particularly in the abdominal region (visceral fat), as well as the accumulation of fat within skeletal muscles (myo-steatosis) and the liver (hepatic steatosis), all of which exacerbate IR [54,55].”
The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
Goya, T., Imoto, K., Tashiro, S., Aoyagi, T., Takahashi, M., Kurokawa, M., Suzuki, H., Tanaka, M., Kato, M., Kohjima, M., et al. (2022) · Gastroenterology Insights · doi:10.3390/gastroent13010003 · Cited by 8
Kim, J., Jeong, K., Lim, S., Lee, S. W., & Baek, Y.-H. (2023) · Metabolites · doi:10.3390/metabo14020130 · Cited by 8
“Obesity is a low chronic inflammation factor that may lead to the development of SO via the infiltration of lipid deposition in the muscle tissue from extensive fat accumulation [35].”
Backgrounddos Santos, C. A., Fraga-Maia, H., Pitanga, F. J. G., de Almeida, M. D. C. C., da Fonseca, M. D. J. M., Aquino, E. M. L., Cardoso, L. D. O., Griep, R. H., Barreto, S. M., Suemoto, C. K., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13723 · Cited by 8
“The superior performance of HST in predicting sarcopenia when accompanied by obesity can be explained by its close relationship with muscular strength [1, 6, 28, 29].”
Nishizaki, Y., Shimada, K., Tani, S., Ogawa, T., Ando, J., Takahashi, M., Yamamoto, M., Shinozaki, T., Miyazaki, T., Miyauchi, K., et al. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01445-w · Cited by 8
Sarcopenic Obesity: The Underlying Molecular Pathophysiology and Prospect Therapies
Meiliana, A., Dewi, N. M., Defi, I. R., Rosdianto, A. M., Qiantori, A. A., & Wijaya, A. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i4.3176 · Cited by 7
“(10) Thus, we also need a regular assessment of muscle mass and function.”
BackgroundPanagiotou, G., & Brage, S. (2025) · Life · doi:10.3390/life15121911 · Cited by 7
“SO arises through multiple interacting pathways, including protein degradation rather than lack of protein synthesis [34], age-related hormonal decline [35], such as a reduction in sex and adrenal steroids [36,37], growth hormone [38] and vitamin D deficiency [39].”
IGF-1 regulate the expression of uncoupling protein 2 via FOXO1
Watamoto, Y., Futawaka, K., Hayashi, M., Matsushita, M., Mitsutani, M., Song, Z., Koyama, R., Fukuda, Y., Nushida, A., Nezu, S., et al. (2019) · Growth Factors · doi:10.1080/08977194.2020.1739032 · Cited by 7
Insight on sarcopenic obesity and epicatechin as a promising treatment option
Sabarathinam, S., Dhanasekaran, D., & Ganamurali, N. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102856 · Cited by 7
Lymphatic Capillarization in Different Fiber Types of Rat Skeletal Muscles With Growth and Age
Taketa, Y., Tamakoshi, K., Hotta, K., Maki, S., Taguchi, T., & Takahashi, H. E. (2024) · Microcirculation · doi:10.1111/micc.12879 · Cited by 7
Sadji, M., Penelope, M. P. V., Ndeye, F. N., Djibril, T., Ma, G., Zongo, C., Yves, T., Mohamadou, D. S., & Traore, A. S. (2015) · African Journal of Food Science · doi:10.5897/ajfs2015.1344 · Cited by 7
“Treatment of sarcopenia with anabolic hormones has many side effects (Sakuma and Yamaguchi, 2013).”
BackgroundEffect of low visceral fat area on long-term survival of stage I–III colorectal cancer
Kamada, T., Ohdaira, H., Takahashi, J., Aida, T., Nakashima, K., Ito, E., Suzuki, N., Hata, T., Yoshida, M., Eto, K., et al. (2023) · Nutrition · doi:10.1016/j.nut.2023.112302 · Cited by 7
Nutrition, Exercise, and Pharmaceutical Therapies for Sarcopenic Obesity
Wakabayashi, H., & Sakuma, K. (2013) · Journal of Nutritional Therapeutics · doi:10.6000/1929-5634.2013.02.02.5 · Cited by 7
Self-citationHigh abdominal adiposity and low phase angle in overweight renal transplant recipients
Ferreira, T. D. S., Silva, M. I. B., da Costa, M. S., Pontes, K. S. D. S., Castro, F. G., Antunes, V. P., Rosina, K. T. D. C., Barreto, A. P. M. M., Souza, E., & Klein, M. R. S. T. (2019) · Clinical Transplantation · doi:10.1111/ctr.13654 · Cited by 7
Fierro Rodríguez, D. (2025) · Revista de Derecho Civil · Cited by 6
Effect and mechanism of miRNA-144-5p-regulated autophagy in older adults with Sarcopenia
Hu, M., Zhang, Y., Ding, H., Chao, R., & Cao, Z. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00499-8 · Cited by 5
Godziuk, K., Prado, C. M. M., Woodhouse, L. J., & Forhan, M. A. (2021) · Obesity · doi:10.1002/oby.23074 · Cited by 5
“Additionally, there is also the potential that sarcopenic obesity predisposes an individual to weight gain as a result of metabolic rate declines linked with low muscle mass (26).”
BackgroundEffect of whey protein supplementation on body composition of patients undergoing bariatric surgery
Henriques, H. K. F., Kattah, F. M., Piccolo, M. S., Rosa, C. D. O. B., Ventura, L. H. D. A., Cerqueira, F. R., Vieira, C. M. A. F., & Leite, J. I. A. (2023) · Journal Archives of Health · doi:10.46919/archv4n1-005 · Cited by 5
Vella, C. A., Miljkovic, I., Price, C. A., & Allison, M. (2022) · Journal of Physical Activity and Health · doi:10.1123/jpah.2021-0409 · Cited by 5
Kang, D.-W., Koh, S.-H., Kim, M.-K., & Kim, D. (2024) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2023.0394 · Cited by 4
“These changes promote a gradual accumulation of body fat [2] and represent a major contributor to the onset of obesity and metabolic diseases, including type 2 diabetes.”
BackgroundMeller, F. D. O., Grande, A. J., Quadra, M. R., & Schäfer, A. A. (2020) · Revista Brasileira de Medicina do Trabalho · doi:10.47626/1679-4435-2020-533 · Cited by 4
Inflammatory parameters in elderly women with and without sarcopenic obesity
Funghetto, S. S., Silva, A. D. O., Dutra, M. T., Stival, M. M., Barbalho, Y. G. D. S., Leite, M. M., Mota, M. R., de Lima, L. R., & da Silva, I. C. R. (2020) · Multi-Science Journal · doi:10.33837/msj.v3i3.1306 · Cited by 4
“Epidemiological evidence revealed that SO is associated with functional decline (Villareal et al., 2011) and the risk of developing cardiovascular, metabolic and endocrine diseases, denervation and mitochondrial dysfunction (Sakuma and Yamaguchi, 2013).”
BackgroundUntargeted Metabolomic Assay of Prefrail Older Adults after Nutritional Intervention
Jaroch, A., Kozakiewicz, M., Jaroch, K., Główczewska-Siedlecka, E., Bojko, B., & Kędziora–Kornatowska, K. (2022) · Metabolites · doi:10.3390/metabo12050378 · Cited by 4
“Impairment of muscle mass, especially development of sarcopenia, will always have a negative effect on the health status of the older adults [20].”
BackgroundEletroestimulação neuromuscular em pacientes com Covid-19: revisão integrativa da literatura
de Souza, R. M. B., Martins, M. H. F., Souza, J. C. D. S., Sobral, L. A., Jacome, L. M. D. S., de Oliveira, G. G. B., Souza, J. P. M. D., de Silva, R. T., Rodrigues, M. E. I., & de Carvalho, T. N. D. A. F. (2022) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e10599.2022 · Cited by 4
Nagaoka, U., Shimizu, T., & Uchihara, T. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2189-y · Cited by 4
A Review on Sarcopenic Obesity: A Rising Epidemic
Dasgupta, P. (2015) · Research Publications (Maastricht University) · Cited by 4
Alzuwaydi, A., Alshammari, G. M., Mohammed, M. A., Qaisar, R., Hussain, M. A., & Alkahtani, S. A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1538002 · Cited by 3
“Previous studies have shown that the effects of aging are greater when sarcopenia is associated with metabolic syndrome (77, 78).”
Nishikawa, H., Nishikawa, T., Fukuda, A., Ushiro, K., Matsui, M., Onishi, S., Kim, S. K., & Asai, A. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5250-25 · Cited by 3
“Inflammation also has negative effects on the skeletal muscle directly via proteolysis or indirectly via reductions in growth hormone and insulin like growth factor-1, which promote muscle protein synthesis (34).”
Tata, R. K., Rao, A. R., Poonia, Y., Chatterjee, P., Mehta, P. K., & Chakrawarty, A. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07098-2 · Cited by 3
“A vicious interaction cycle between muscle and fat cells (myocyte-adipocyte crosstalk) drives atrophy and fat deposition [14, 15].”
Kim, J. J., Bressel, E., Kim, M., Kim, T., Koh, S.-H., & Kim, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144981 · Cited by 3
“Furthermore, IL-15 has the potential to inhibit adipocyte differentiation and reverse diet-induced obesity [12].”
O desafio do aleitamento materno: Promoção e incentivo nas equipes de Saúde da Família
de Oliveira, L. G. A., & de Abrantes, M. J. G. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.03 · Cited by 3
Mizukami, Y., Onishi, H., Mifuku, Y., Kubota, M., Ikeda, R., Hayashi, H., & Yamamura, O. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-33 · Cited by 3
“Although the effect of myositis is unknown in the present study, a response similar to that described by Sakuma et al. (19) and Woodrow (20) may be occurring.”
Underlying mechanisms of sarcopenic obesity
Rauen, M., Bollheimer, L. C., & Nourbakhsh, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822146-4.00005-3 · Cited by 3
The Correlation of Serum Myostatin Levels with Gait Speed in Kidney Transplantation Recipients
Huang, P.-Y., Tsai, J.-P., Chen, Y.-C., Lee, M.-C., & Hsu, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010465 · Cited by 3
Taketa, Y., & Takahashi, H. E. (2025) · Journal of Toxicologic Pathology · doi:10.1293/tox.2025-0072 · Cited by 2
“These findings suggest that age-related skeletal muscle mass decline may result from a decrease in the total number of muscle fibers and an increase in body fat 13, 14 .”
The therapeutic potential of natural killer (NK) cells to combat aging and age-related diseases
Bari, R., Kang, L., Gosiewska, A., & HARIRI, R. J. (2026) · Discover Immunity. · doi:10.1007/s44368-026-00021-2 · Cited by 2
Graham, H. L., Asakura, Y., Kirby, J. B., Prue-Owens, K., & Ma, J. (2023) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001009 · Cited by 2
“49 Specifically, women are more likely than men to experience their first cardiac event later in life, to present clinically with more comorbidities, 51 to experience delay in diagnosis, and to receive fewer provider referrals for CR. 52 Of the studies conducted among women with CVD, findings…”
BackgroundResultCostanzo, M., Cisterna, B., & Malatesta, M. (2013) · doi:10.4081/microscopie.2013.4988 · Cited by 2
Association of aging-related obesity and metabolic syndrome in men
Pinkhasov, B. B., Selyatitskaya, V. G., Karapetyan, A. R., & Lutov, Y. V. (2016) · Advances in Gerontology · doi:10.1134/s2079057016030085 · Cited by 2
“Testosterone, the most important male sex steroid, stimulates the increase of muscle mass [17], promotes normalization of the carbohydrate and lipid metabolisms, and reduces the degree of abdominal obesity upon aging in men [18].”
BackgroundObesidade sarcopênica e risco para óbito em idosos brasileiros
da Rocha, M. A. P. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2015.tde-09102015-083138 · Cited by 2
Song, G. Y. (2025) · Korean Journal of Geriatrics & Gerontology · doi:10.15656/kjgg.2025.26.1.9 · Cited by 1
Lisco, G., Tullio, A. D., Disoteo, O., Dicorato, P., Tortora, A., Geronimo, V. D., & Triggiani, V. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10033-w · Cited by 1
“…levels - which impair skeletal muscle utilization of energy substrates and ultimately compromise myofibrillar protein synthesis - indi - viduals with obesity also exhibit lower circulating levels of growth hormone (GH) and total testosterone compared with healthy, age-matched controls [39].”
Yu, Y., He, Y., Wang, Y., Wu, C., Zhou, R., Chen, F., & Ma, W. (2026) · The FASEB Journal · doi:10.1096/fj.202601360r · Cited by 1
“This IL-15 decline represents a shared pathological feature contributing to both sarcopenia and obesity development [164, 165].”
Ge, D., Yu, Y., 饶进, Ren, H., Wang, Z., & Zhang, B. (2026) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303440752251229094023 · Cited by 1
Abdallah, H., Khalil, M., Mahdi, L., Pietragalla, G., Faienza, M. F., Garruti, G., & Portincasa, P. (2026) · Nutrients · doi:10.3390/nu18142317 · Cited by 1
“[50,51]”
Molecular Biomarkers of Aging Studies in Humans
Pedraza-Vázquez, G., Alarcón‐Aguilar, A., & Luna‐López, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_6 · Cited by 1
Uso de tecnologias do cuidado na assistência ao parto normal em um Hospital Universitário
Carneiro, K. F. P., Skupien, S. V., Ravelli, A. P. X., Campos, C. G. P., Rinaldi, E. C. A., Baier, L. D. C. D., & de Souza, J. C. R. F. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.02 · Cited by 1
Lee, S. R., Lee, Y. L., & Lee, S. Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1015351 · Cited by 1
THE ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND OBESITY IN YOUNG ADULTS: A CASE CONTROL STUDY
Mustafa, A., Zia, T., Tasneem, S., Kubra, K. T., & Latif, M. (2024) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/jptcp.v31i1.3968 · Cited by 1
Troshina, E. A., Bogdanova, V. O., & Umarkhadzhieva, Z.-S. R. (2025) · Obesity and metabolism · doi:10.14341/omet13180 · Cited by 1
Mbuthia, G. W., Ndithia, J. M., Oguta, J. O., Akoth, C., Magutah, K., Kawira, R., Nyariki, C. K., Kimutai, N., Kinyua, A., & McGarvey, S. T. (2023) · medRxiv · doi:10.1101/2023.08.08.23293819 · Cited by 1
Impact de la citrulline sur le métabolisme du tissu adipeux
Joffin, N. (2015) · theses.fr (ABES) · doi:10.70675/a8f99427z3518z4103z8d8cz1e35e9d020d8 · Cited by 1
Fisher, K. L. (2014) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
Rech, A. (2014) · Americanae (AECID Library)
Glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1 and the aged phenotype
Hassan-Smith, Z. K. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Vecino, B. M. (2015) · RUIdeRA - Institutional University Repository (University of Castilla-La Mancha)
The Relationship Between Adiponectin Levels and Appendicular Lean Mass in Postmenopausal Women
Puchala, S. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Wawrzeńczyk, A., Anaszewicz, M., Banaś, W., Spychalska-Zwolińska, M., Socha, E., Lis, K., Żbikowska-Götz, M., Bartuzi, Z., & Budzyński, J. (2018) · Medical Research Journal · doi:10.5603/mrj.2018.0015
“These results may have some impact on knowledge concerning muscle adipose tissue crosstalk [11], sarcopenic obesity [13, 24] and its organic complications, especially concerning liver steatosis [25], patients’ functional status [1, 8], and obesity-related all-cause mortality [4, 26].”
BackgroundNguyen, M. (2018) · Papyrus : Institutional Repository (Université de Montréal)
da Silva, V. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.100.2019.tde-22062019-221711
Características nutricionales de los pacientes con cirrosis hepática
Conde, M. H. (2020) · Biblos-e Archivo (Universidad Autónoma de Madrid)
Kim, J. H., Jeon, S., Jeong, H. J., & Jeon, M. Y. (2017) · Journal of Korean Biological Nursing Science · doi:10.7586/jkbns.2020.22.2.139
“육량이 감소하여 지방대사 및 에너지 소비가 저하되면서[3] 체지방 량이 증가하고 당 내성이 증가되기 때문이다[4].”
Kim, K. (2020) · The Korean Journal of Sports Medicine · doi:10.5763/kjsm.2020.38.3.155
Frailty and obesity in ageing men
Ravindrarajah, R. (2015) · Research Explorer (The University of Manchester)
Ribeiro, D. I., & Rosa, R. T. A. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.05
Rodrigues, P. F., & de Assis, M. A. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.16
Sensor de mudança de decúbito: Uma tecnologia como auxílio na prevenção das lesões por pressão
da Cruz, A. M. M., Fernandes, A. A. R., Prismic, C. R., Viana, D. F., Barreiros, L. D. N., & Prismic, V. F. D. S. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.21
da Costa, M. A. C., & do Nascimento, M. C. K. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.04
Terapia Comunitária Integrativa Virtual: Conexões em tempos de pandemia
Carneiro, A. L. B., Ramos, S. C. D. S., Ribeiro, R. M., de Melo, M. N. A., de Melo, C. D. M. B., de Aguiar, P. K. F., Monteiro, B. R., Ferreira, M. D. L., Falcão, P. B. L., Maciel, J. J. D. S., et al. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.13
de Carvalho, J. P. M., Filho, E. D., Narciso, A. G., & Mansani, F. P. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.24
Obesidade sarcopênica no envelhecimento
Costodio, A. R., de Lima, K. P., & Dallepiane, L. B. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.19
Análise de redes sociais no handebol: As métricas globais explicam o número de gols marcados?
Trindade, L. N., Paiola, T. F., de Godoy, A. W., Lucio, L. A., Teixeira, D., Marques, P. G., & Borges, P. H. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.25
Yoshizawa, D. H., Borato, D. C. K., Dec, A. T. D. S., Maciel, M. A. S., & Bortoli, S. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.10
Fatores associados a Tuberculose em trabalhadores da construção civil
ALMEIDA, R. A. D., de Medeiros, S. M., & Lyra, W. D. S. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.06
Nolêto, D. C. D. S., da Silva, R. D., Pessoa, D. R., Leal, S. S., & Alves, W. D. S. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.22
de Oliveira, R. A., do Nascimento, G. L. S., da Silva, K. R., da Silva, L. A., & Mota, F. P. M. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.20
Caracterização da assistência de enfermagem no Acidente Vascular Encefálico
Evangelista, W. D. A., de Brito, D. G. C., Albuquerque, L. D. S. S., Rodrigues, L. G. L., Silva, L. G. D. S., & Dantas, A. P. G. D. F. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.11
Plantas medicinais e os santos populares no Brasil
Madeiro, L. S., Nóbrega, A. S., Pereira, V. N. D. A., & de Oliveira, R. A. G. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.01
de Jesus, A. P. B., Silva, D. A. R. R., Farias, J. D. S., & de Souza, A. F. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.09
Nakamatsu, M. H. G., Maciel, M. A. S., Dec, A. T. D. S., & Simionatto, M. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.08
Deficiência de vitamina B12 associada a Anemia em idosos
de Melo, A. P., Borato, D. C. K., Bortoli, S., Dec, A. T. D. S., & Maciel, M. A. S. (2021) · Editora Poisson eBooks · doi:10.36229/978-65-5866-044-6.cap.18
Metadata
- Authors
- Sakuma, K., & Yamaguchi, A.
- Affiliations
- Toyohashi University of Technology (JP)
- Health Sciences University of Hokkaido (JP)
- Corresponding author
- Sakuma, Kunihiro
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-12
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC3639625
- OpenAlex
- W1966294329
- Cited by
- 189
- References
- 183
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 16 · 2023: 13 · 2022: 20 · 2021: 20 · 2020: 20 · 2019: 9 · 2018: 9 · 2017: 8 · 2016: 14 · 2015: 15 · 2014: 12 · 2013: 4
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology of Japan (23500578)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenic obesity, sarcopenia, aging, body composition, muscle mass loss, frailty, obesity, inflammation, TNF-α, interleukin-6, leptin, myostatin, adiponectin, IL-15, caloric restriction, physical activity, myostatin inhibition, glucose homeostasis, skeletal muscle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.